Publication:
Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: A systematic review and meta-analysis

dc.contributor.authorAnan Chuasuwanen_US
dc.contributor.authorSiriporn Pooripussarakulen_US
dc.contributor.authorAmmarin Thakkinstianen_US
dc.contributor.authorAtiporn Ingsathiten_US
dc.contributor.authorOraluck Pattanaprateepen_US
dc.contributor.otherBhumibol Adulyadej Hospitalen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2020-08-25T10:35:22Z
dc.date.available2020-08-25T10:35:22Z
dc.date.issued2020-06-18en_US
dc.description.abstract© 2020 The Author(s). Objective: End-stage renal disease (ESRD) leads to renal replacement therapy and certainly has an impact on patients' health-related quality of life (HRQoL). This study aimed to review and compare the HRQoL between peritoneal dialysis (PD) and hemodialysis (HD) patients using the 36-Item Short Form Health Survey (SF-36), EuroQoL-5-dimension (EQ-5D) and the Kidney Disease Quality of Life Instrument (KDQOL). Methodology: Systematic review was conducted by identify relevant studies through MEDLINE and SCOPUS up to April 2017. Studies were eligible with following criteria: studied in ESRD patients, compare any pair of renal replacement modalities, and reported HRQoL. The unstandardized mean differences (USMD) of HRQoL among modalities were calculated and pooled using a random-effect models if heterogeneity was present, otherwise a fixed-effect model was applied. Results: A total of twenty-one studies were included with 29,000 participants. Of them, mean age and percent male were 48.1 years and 45.1, respectively. The pooled USMD (95% CI) of SF-36 between PD and HD (base) were 1.86 (0.47, 3.24) and 0.42 (- 1.99, 2.82) for mental component and physical component summary scores, respectively. For EQ-5D, the pooled USMD of utility and visual analogue scale (VAS) score were 0.02 (- 0.06, 0.10) and 3.56 (1.73, 5.39), respectively. The pooled USMD of KDQOL were 9.67 (5.67, 13.68), 6.71 (- 5.92, 19.32) 6.30 (- 0.41, 12.18), 2.35 (- 4.35, 9.04), 2.10 (0.07, 4.13), and 1.21 (- 2.98, 5.40) for burden of kidney disease, work status, effects of kidney disease, quality of social interaction, symptoms, and cognitive function. Conclusion: Patients with chronic kidney disease (CKD) stage 5 or ESRD treated with PD had better generic HRQoL measured by SF-36 and EQ-5D than HD patients. In addition, PD had higher specific HRQoL by KDQOL than HD patients in subdomain of physical functioning, role limitations due to emotional problems, effects and burden of kidney disease.en_US
dc.identifier.citationHealth and Quality of Life Outcomes. Vol.18, No.1 (2020)en_US
dc.identifier.doi10.1186/s12955-020-01449-2en_US
dc.identifier.issn14777525en_US
dc.identifier.other2-s2.0-85086694422en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/58123
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086694422&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleComparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: A systematic review and meta-analysisen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086694422&origin=inwarden_US

Files

Collections